Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Prescription Pain Medication Market From 2025 To 2029?
The market size for prescribed painkillers has consistently expanded over the past few years. The market’s projected growth is from $73.59 billion in 2024 to $77.22 billion in 2025, with a compound annual growth rate (CAGR) of 4.9%. The rise during the historical period is due to an escalating frequency of chronic pain, growing count of surgical procedures, a heightened emphasis on palliative care, and a surging occurrence of musculoskeletal disorders.
There is an anticipated robust expansion in the prescription pain medication market in the forthcoming years, with its size expected to surge to $95.11 billion in 2029, at a compound annual growth rate (CAGR) of 5.3%. The expansion in the projected period can be linked to the rising demand for individualized medication, an increased emphasis on managing post-traumatic pain, the escalating adoption of telemedicine for pain control, an augmented count of patients favoring opioid alternatives, as well as a growing incidence of neuropathic pain. Key trends in the projected period involve the development of non-opioid pain substitutes, the incorporation of digital health solutions, innovations in targeted pain treatments, formulating combination pain drugs, and breakthroughs in non-addictive pain medications.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24385&type=smp
Which Factors and External Forces Are Driving Demand in the Prescription Pain Medication Market?
The growing incidence of arthritis is likely to boost the expansion of the market for prescription pain medications. Defined as inflammation of one or more joints, arthritis results in pain, swelling, stiffness, and a diminished range of motion. This rise in arthritis cases is largely attributed to obesity, as extra body weight exerts more stress on joints, especially the knees, and triggers inflammation. Prescribed painkillers assist in handling arthritis by diminishing inflammation and pain, facilitating better performance of joints, and bettering the overall life quality of the patients. For example, as per a report by the Office for Health Improvement and Disparities, a government department based in the UK, in March 2023, the percentage of individuals aged 16 and above dealing with arthritis or ongoing back or joint issues rose to 17.6% in 2022, up from 17.0% the previous year i.e., 2021. Hence, the escalation in autoimmune disorders’ incidence is propelling the growth in the market for prescription pain medications.
Which Segments in the Prescription Pain Medication Offer the Most Growth?
The prescription pain medication market covered in this report is segmented –
1) By Type: Prescription Non-Steroidal Anti-Inflammatory Drugs, Opioids, Anti-Epileptic Medicines, Antidepressants, Other Types
2) By Route Of Administration: Oral, Injectable, Transdermal, Other Route Of Administrations
3) By Application: Neuropathic Pain, Cancer Pain, Post-Operative Pain, Other Applications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Prescription Non-Steroidal Anti-Inflammatory Drugs: COX-2 Inhibitors, Traditional Non-Steroidal Anti-Inflammatory Drugs, Combination Non-Steroidal Anti-Inflammatory Drugs
2) By Opioids: Strong Opioids, Mild Opioids, Opioid Combination Medications
3) By Anti-Epileptic Medicines: Sodium Channel Blockers, Gamma-Aminobutyric Acid Modulators, Glutamate Inhibitors
4) By Antidepressants: Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants, Serotonin-Norepinephrine Reuptake Inhibitors, Other Antidepressants
5) By Other Types: Muscle Relaxants, Topical Pain Medications, Corticosteroids
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24385&type=smp
What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Prescription Pain Medication Market?# Market?
North America was the largest region in the prescription pain medication market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription pain medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Prescription Pain Medication Market?
The primary players in the prescription pain medicine market are investing in the development of alternative treatment options such as non-opioid analgesics. These are designed to mitigate the escalating issue of opioid dependency and enhance the safety of patients. Non-opioid analgesics present a safer and effective alternative for enduring pain management, lowering the chances of addiction and overdose. One noteworthy example of this is the approval granted by the U.S. Food and Drug Administration (FDA) to Vertex Pharmaceuticals Incorporated, a biotech company headquartered in the US, for their non-opioid oral medication JOURNAVX in January 2025. This drug focuses on blocking NaV1.8 sodium channels in peripheral nerves, eliminating the pain signals without impacting the central nervous system, and successfully providing acute pain relief without any risk of addiction. Demonstrating significant pain reduction during Phase 3 trials for abdominoplasty and bunionectomy via a twice-daily dosage, this unrelated to a controlled substance medication addresses the pressing requirement for more secure acute pain management.
View the full report here:
https://www.thebusinessresearchcompany.com/report/prescription-pain-medication-global-market-report
What Are the Key Elements That Define the Prescription Pain Medication Market?
Prescription pain medication refers to drugs that are legally prescribed by a licensed healthcare provider to help manage moderate to severe pain. These medications are stronger than over-the-counter (OTC) pain relievers and are used when pain cannot be adequately controlled with non-prescription options.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24385
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
